The Wisconsin Medical Society holds an Annual Meeting every spring.

Although a virtual meeting is not ideal, we are committed to a format centered around conversations between Society officers and members in a way that will be engaging, inclusive and provide insights into what is most relevant and needed by members.

Contact membership@wismed.org for questions.

Annual Meeting - Saturday April 9, 2022 

9:00 – 9:30 a.m.
Welcome & Introduction
Past President Address
President’s Farewell and Presentation of Past-President’s Award
Installment of President & Treasurer
Incoming President’s Address
Treasurer’s Report

9:30 – 9:35 a.m.
Society CEO
Introduction of Mike Flesher, the Society’s new CEO
Farwell message from Bud Chumbley, MD

9:35 – 10:35 a.m.
COVID-19 Therapeutics
Presented by Jonathan Meiman, MD, Chief Medical Officer and State Epidemiologist for Occupational and Environmental Health, Wisconsin Department of Health Services and Deanna Olexia, Enterprise Coordinator for the Antimicrobial Stewardship (AMS) Program at Froedtert & the Medical College of Wisconsin

BREAK 10:35 – 10:45 a.m.

10:45 – 10:50 a.m.
Society Awards

10:50 – noon
Advocacy update & PolicyLink overview
Presented by Mark Grapentine, Chief Policy and Advocacy Officer, Wisconsin Medical Society

COVID-19 Therapeutics Guest Speakers

Dr. Jonathan Meiman is the Chief Medical Officer and State Epidemiologist for Environmental and Occupational Health at the Wisconsin Department of Health Services. He is the principal investigator for several CDC and EPA grants and is the state’s medical consultant for environmental and occupational diseases. He is a former member of CDC’s Epidemic Intelligence Service and has field experience investigating infectious disease outbreaks, such as MERS-CoV in Saudi Arabia and Ebola in Sierra Leone. Dr. Meiman has worked exclusively on COVID-19 over the past two years and has led healthcare surge activities, including therapeutics distribution, hospital capacity surveillance, and scarce resource allocation.

Deanna Olexia is the Enterprise Coordinator for the Antimicrobial Stewardship (AMS) Program at Froedtert & the Medical College of Wisconsin. She has been actively involved in the development of COVID-19 treatment guidelines and the implementation of COVID-19 outreach programs in partnership with multiple groups from across the health-system. Deanna is the co-leader of the Antimicrobial Stewardship Workgroup, collaborating across a diverse system to optimize antimicrobial use and improve patient outcomes. She is involved in various research projects and program initiatives, most recently partnering to expanding antimicrobial stewardship services to the ambulatory clinics.